Key opportunities in the buprenorphine patch market include enhancing opioid stewardship, leveraging digital prescribing, securing robust supply chains, and aligning clinical protocols with payer and ...
September 28, 2010 (Las Vegas, Nevada) — A transdermal application system containing the partial μ-opioid receptor agonist buprenorphine showed analgesic efficacy in the treatment of low back pain in ...
ICD is much more common than ACD among users of the buprenorphine TTS. During the clinical development of the buprenorphine TTS, three double-blind placebocontrolled parallel group studies and one ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback